Eric Nuremberger

41PUBLICATIONS
82CO-AUTHORS
Medical mycologyBasic pharmacologyMolecular targetsMedical bacteriologyBiomedical instrumentation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Aug 20, 2026
Predicting tuberculosis relapse based on 28-day CFU, RS ratio, and/or drug contribution for novel regimens in the relapsing mouse model.

|Feb 12, 2026
Predicting early bactericidal activity of tuberculosis drug combinations using a translational pharmacokinetic-pharmacodynamic modeling approach.

Niurys de Castro Suarez, Eric L Nuermberger, Jacqueline Ernest

|Oct 22, 2025
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens.

Clara Aguilar-Pérez, Anne J Lenaerts, Cristina Villellas

|Jun 02, 2025
A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis.

Veronique de Jager, Laurynas Mockeliunas, Huifang You

|Apr 23, 2025
The KasA inhibitor JSF-3285 improves the sterilizing activity of bedaquiline-pretomanid-containing regimens in a mouse model of tuberculosis.

Heena Soni, Sandeep Tyagi, Kishor Mane

|Apr 22, 2025
Efficacy of novel regimens targeting oxidative phosphorylation in Mycobacterium tuberculosis.

Dongshuo Li, Liang Li, Ye Zhang

Pageof 7

Frequent Collaborators

9 joint publications

Radojka M Savic

7 joint publications

Nicole C Ammerman

5 joint publications

Jacqueline P Ernest

4 joint publications

Gregory T Robertson